Nephrol Dial Transplant (2003) 18: 884-887
© 2003 European Renal Association-European Dialysis and Transplant Association
Iron-mobilizing properties of the gadoliniumDTPA complex: clinical and experimental observations
1 Department of Nephrology and 2 Department of Pathology, Soroka Medical Center, Ben Gurion University of the Negev, Faculty of Health Sciences, Beer Sheva, Israel
Background. Gadolinium (Gd) magnetic resonance imaging (MRI) contrast agents are considered to be safe in patients with impaired renal function. Our study investigates a mechanism of severe iron intoxication with life-threatening serum iron levels in a haemodialysis patient following MRI with Gddiethylenetriaminepentaacetic acid (GdDTPA) administration. His previous history was remarkable for multiple blood transfusions and biochemical evidence of iron overload. We hypothesized that GdDTPA may have an iron-mobilizing effect in specific conditions of iron overload combined with prolonged exposure to the agent.
Methods. For the in vitro study, GdDTPA was added to mice liver homogenate and iron metabolism parameters were measured after incubation in comparison with the same samples incubated with saline only. For the in vivo study, an experimental model of acute renal failure in iron-overloaded rats was designed. Previously iron-overloaded and normally fed rats underwent bilateral nephrectomy by renal pedicle ligation, followed by GdDTPA or saline injection. Iron and iron saturation levels were checked before and 24 h after GdDTPA or vehicle administration.
Results. Significant mobilization of iron from mice liver tissue homogenate in mixtures with Gd in vitro was seen in the control (saline) and in the experimental (Gd) groups (513±99.1 vs 1117.8±360.8 µg/dl, respectively; P<0.05). Administration of GdDTPA to iron-overloaded rats after renal pedicle ligation caused marked elevation of serum iron from baseline 143±3.4 to 570±8 µg/dl (P<0.0001). There were no changes of the named parameter, either in iron-overloaded anuric rats after saline injection or in normal diet uraemic animals, following GdDTPA administration.
Conclusions. The combination of iron overload and lack of adequate clearance of Gd chelates may cause massive liberation of iron with dangerous elevation of free serum iron. It is highly recommended that after Gd contrast study, end-stage renal disease patients with probable iron overload should undergo prompt and intensive haemodialysis for prevention of this serious complication.
Keywords: chelate; dialysis; gadolinium; iron overload; renal failure; GdDTPA
Correspondence and offprint requests to: Dr Marina Vorobiov, Department of Nephrology, Soroka Medical Center, Ben Gurion University of the Negev, Center of Health Sciences, PO Box 151, Beer Sheva 84101, Israel. Email: marinavorobiov{at}netscape.net
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
T. A. Hope, W. A. High, P. E. LeBoit, B. Chaopathomkul, V. S. Rogut, R. J. Herfkens, and R. C. Brasch Nephrogenic Systemic Fibrosis in Rats Treated with Erythropoietin and Intravenous Iron Radiology, November 1, 2009; 253(2): 390 - 398. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Grobner Gadolinium - a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? Nephrol. Dial. Transplant., April 1, 2006; 21(4): 1104 - 1108. [Full Text] [PDF] |
||||

